# Cresilon

its biomimetic hemostatic gel, marketed as TraumaGel, showed promising results for treating penetrating traumatic brain injury in a study with the Walter Reed Army Institute of Research, received an Innovative Technology contract from Vizient, and was named to Fast Company's Most Innovative Companies list for 2026.

Source: https://en.bioecon.ru/companies/cresilon/
Updated: 2026-07-20

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $158.3M total funding (2026-04-29) | https://commercialobserver.com/2025/06/cresilon-lease-brooklyn-industry-city/ |
| Capacity | 55,000 square foot biomanufacturing facility in Brooklyn (2026-03-01) | https://commercialobserver.com/2025/06/cresilon-lease-brooklyn-industry-city/, https://www.biospace.com/press-releases/cresilon-named-one-of-the-worlds-50-most-innovative-companies-by-fast-company |
| Regulatory approval | FDA 510(k) clearance for TRAUMAGEL for temporary external use to control moderate to severe bleeding (2024-08-15) | https://cresilon.com/2024/07/09/cresilons-revolutionary-hemostatic-gel-technology-shows-promising-results-for-treatment-of-penetrating-traumatic-brain-injury-in-study-performed-with-walter-reed-army-institute-of-research/, https://cresilon.com/2024/08/15/cresilon-receives-fda-clearance-for-traumagel/, https://www.ijpsjournal.com/article/traumagel-a-revolutionary-fda-approved-newly-introduced-hemostatic-agent |
| Regulatory approval | FDA 510(k) clearance for Cresilon Hemostatic Gel (CHG) for local management of minor bleeding wounds (2023-06-01) | https://cresilon.com/2024/07/09/cresilons-revolutionary-hemostatic-gel-technology-shows-promising-results-for-treatment-of-penetrating-traumatic-brain-injury-in-study-performed-with-walter-reed-army-institute-of-research/, https://www.prnewswire.com/news-releases/cresilons-revolutionary-hemostatic-gel-technology-shows-promising-results-for-treatment-of-penetrating-traumatic-brain-injury-in-study-performed-with-walter-reed-army-institute-of-research-302191358.html |
| Headcount | approximately 92 employees (2026-07-01) | https://commercialobserver.com/2025/06/cresilon-lease-brooklyn-industry-city/ |
| Revenue | $3.0M annual revenue (2025-01-01) [medium confidence] | https://www.zippia.com/cresilon-careers-1401259/revenue/ |
| Production site | 55,000 square foot facility in Brooklyn's Industry City (2026-03-01) | https://commercialobserver.com/2025/06/cresilon-lease-brooklyn-industry-city/ |

Independent sources: biospace.com, commercialobserver.com, ijpsjournal.com, prnewswire.com, zippia.com

## Technologies

- [Biomimetic medical adhesives](https://en.bioecon.ru/technology/biomimetic-medical-adhesives/)